CTGL — Citrine Global Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.10m
- $2.28m
Annual cashflow statement for Citrine Global, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.16 | -1.87 | -8.64 | -4.52 | -2.65 |
| Depreciation | |||||
| Non-Cash Items | -0.119 | 0.432 | 7.72 | 1.64 | 1.43 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.134 | 0.186 | 0.22 | 2.29 | 0.648 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.39 | -1.23 | -0.696 | -0.582 | -0.567 |
| Capital Expenditures | -0.098 | -0.011 | -0.006 | -0.252 | -0.004 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.015 | 0.038 | -0.609 | 0.538 | 0.015 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.113 | 0.027 | -0.615 | 0.286 | 0.011 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.37 | 0.757 | 1.5 | 0.35 | 0.36 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.115 | -0.457 | 0.189 | 0.074 | -0.203 |